EU Investment of €2 Million to Fund PrepSia™ pregnancy screening
Having been ranked among the top innovations in Europe, Metabolomic Diagnostics is set to re...
Irish biotech company, Metabolomic Diagnostics, has secured an additional €1.6 million in venture funding to help complete PrePsia, its new screening test for f...